Leerink Partnrs Raises Earnings Estimates for Exact Sciences
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2025 EPS estimates for shares of Exact Sciences in a research report issued to clients and investors on Thursday, February 20th. Leerink Partnrs analyst P. Souda now expects that the medical research company will earn $0.12 per share for […]
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2025 EPS estimates for shares of Exact Sciences in a research report issued to clients and investors on Thursday, February 20th. Leerink Partnrs analyst P. Souda now expects that the medical research company will earn $0.12 per share for […]